The Journal of Infectious Diseases · 1999 · 131 citations · 32 references
Life SciencesImmunologyInfectious DiseasesImmunizationImmunology Of Infectious DiseasesMucosal ImmunologyBacterial ImmunologyHumoral ImmunityMucosal Immune SystemMucosal ImmunityMucosal ImmunizationMucosal VaccinesAntibodiesAntigen-specific Antibody ResponsesAntigen-specific Immune ResponseMucosal Immunoglobulin A (Iga) ResponsesMucosal Vaccine EfficacyNasal VaccinationNasal VaccinesTh2 Immune Response
To determine the efficacy of a mucosal vaccine against nontypeable Haemophilus influenzae (NTHi), mice were immunized nasally, orally, intratracheally, or intraperitoneally with NTHi antigen together with cholera toxin. Antigen-specific IgA antibody titers in nasal washes and the numbers of antigen-specific IgA-producing cells in nasal passages showed the greatest increases in mice immunized nasally. Cytokine analysis showed that interferon-gamma, interleukin (IL)-2, IL-5, IL-6, and IL-10 were induced by nasal immunization, suggesting that Th2- and Th1-type cells were generated. Furthermore, bacterial clearance of a homologous strain of NTHi from the nasal tract was significantly enhanced in the nasal immunization group. These findings suggest that nasal immunization is an effective vaccination regimen for the induction of antigen-specific mucosal immune responses, which reduce the colonization of NTHi in the nasal tract.
32
IL-4 directs the development of Th2-like helper effectors.
Susan L. Swain, Andrew D. Weinberg, M English et al. · The Journal of Immunology · 1990 · 1.3K citations · Full text
J Xu-Amano, Hiroshi Kiyono, R J Jackson et al. · The Journal of Experimental Medicine · 1993 · 451 citations · Full text